HIV immunogenic complexes
US5843454A · kind A · utility
19Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 1995 |
| Grant date | Dec 1, 1998 |
| Priority date | — |
| Expiry date | Dec 20, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A vaccine and a method of raising neutralizing antibodies against HIV infection. The vaccine comprises a complex of gp120 covalently bonded to CD4 or to succinyl concanvalin A. Also disclosed are immunological tests using the complex or antibody thereto for detection of HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.